Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Intranasal naloxone spray could reduce opioid-related deaths
Naloxone has long been used by emergency responders in cases of known or suspected opioid overdose. It has been accessible over-the-counter (OTC) in an...
Top tips for becoming a sought-after GP pharmacist
With many GPs seeing the value of multidisciplinary care teams including pharmacists, here's how to become a GP pharmacist.
Pharmacy prescribing trial expands to include skin conditions
With New South Wales recently expanding its pharmacy prescribing trial to include skin conditions, could other jurisdictions soon follow?
Pharmacists’ guide to vaping supply arrangements
When the Commonwealth’s legislated vaping reforms come into effect tomorrow, pharmacists need to adhere to a new set of regulations for Schedule 3 supply...
World Pharmacists Day 2020
In the lead up to World Pharmacists Day on Friday, pharmacists around the country have expressed pride, passion and excitement for their work, the importance of which has been highlighted during a difficult year.
Synthetic opioids ‘one of the biggest threats’ to drug-related harm
Australia should prepare now for a potential influx of synthetic opioids into the illicit drug market, an expert has told Australian Pharmacist, as overdoses increase internationally.
